Back to BAKER BROS. ADVISORS LP

XENE
Showing 8 of 24 quarters

Position history for BAKER BROS. ADVISORS LP's holdings in XENON PHARMACEUTICALS INC

BAKER BROS. ADVISORS LP holds 370,208 shares of XENE (XENON PHARMACEUTICALS INC), worth $21.5M as of 2026-Q1. XENE represents 0.1% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$21.5M

Current Shares

370,208

Total Value Change

-$17.2M

Total Shares Change

-623,471

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
370,208
0.0%
$21.5M0.1%$43.79
0
2025-Q4
Unchanged
370,208
0.0%
$16.6M0.1%$44.12
0
2025-Q3
Unchanged
370,208
0.0%
$14.9M0.1%$39.06
0
2025-Q2
Increased
370,208
+6.6%
$11.6M0.1%$32.40
36
2025-Q1
Decreased
347,408
-65.0%
$11.7M0.1%$34.26
0
2024-Q4
Unchanged
993,679
0.0%
$39M0.4%$38.53
0
2024-Q3
Unchanged
993,679
0.0%
$39.1M0.4%$38.65
0
2024-Q2
Unchanged
993,679
0.0%
$38.7M0.5%$38.99
0

Other major holders of XENE: FMR LLC, Avoro Capital Advisors LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used